ERAP1 and psoriasis: Indeed, changes in the immunopeptidome due to ERAP1 SNPs are exacerbated in the individuals carrying HLA class I loci conferring risks to disease—HLA-B27 for AS, HLA-Cw*06 for psoriasis, and HLA-B*51 for BD.